Mirum Pharmaceuticals Inc (MIRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -87,942 | -163,415 | -135,665 | -83,988 | -103,270 |
| Depreciation Amortization | 25,290 | 11,946 | 3,238 | 595 | 623 |
| Income taxes - deferred | N/A | N/A | -6,580 | N/A | N/A |
| Accounts receivable | -11,426 | -43,974 | -20,727 | N/A | N/A |
| Other Working Capital | 22,591 | -19,221 | -21,050 | 16,983 | 611 |
| Other Operating Activity | 61,812 | 143,720 | 60,648 | -66,348 | 12,961 |
| Operating Cash Flow | $10,325 | $-70,944 | $-120,136 | $-132,758 | $-89,075 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -69,132 | 125,671 | 7,978 | -40,429 | 38,099 |
| PPE Investments | -993 | -109 | -278 | -24 | -225 |
| Net Acquisitions | N/A | -212,762 | N/A | N/A | N/A |
| Purchase Sale Intangibles | -20,000 | -20,000 | N/A | -19,000 | N/A |
| Other Investing Activity | -20,000 | -20,000 | 0 | 89,000 | 0 |
| Investing Cash Flow | $-90,125 | $-107,200 | $7,700 | $48,547 | $37,874 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 305,304 | N/A | N/A | N/A |
| Common Stock Issued | 17,699 | 227,154 | 114,639 | 9,012 | 131,871 |
| Other Financing Activity | 0 | -195,858 | -5,552 | 64,454 | 49,417 |
| Financing Cash Flow | $17,699 | $336,600 | $109,087 | $73,466 | $181,288 |
| Exchange Rate Effect | -1,297 | -133 | 12 | -1 | 29 |
| Beginning Cash Position | 286,326 | 128,003 | 131,340 | 142,086 | 11,970 |
| End Cash Position | 222,928 | 286,326 | 128,003 | 131,340 | 142,086 |
| Net Cash Flow | $-63,398 | $158,323 | $-3,337 | $-10,746 | $130,116 |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,325 | -70,944 | -120,136 | -132,758 | -89,075 |
| Capital Expenditure | -993 | -109 | -278 | -24 | -225 |
| Free Cash Flow | 9,332 | -71,053 | -120,414 | -132,782 | -89,300 |